Results 371 to 380 of about 905,763 (403)
Some of the next articles are maybe not open access.
Pharmacotherapy in Ventricular Arrhythmias
Cardiology, 2023Background: Ventricular ectopy is observed in most of the population ranging from isolated premature ventricular contractions to rapid hemodynamically unstable ventricular tachyarrhythmias like ventricular tachycardia and ventricular fibrillation.
Nachiket Apte, Dinesh K. Kalra
openaire +2 more sources
Mapping of Ventricular Arrhythmias
Cardiology Clinics, 1986Mapping of ventricular arrhythmias is essential for their reliable surgical and ablative management. Activation mapping is the most widely used technique but demands induction of the arrhythmia. Mapping strategies that can identify an arrhythmogenic substrate in sinus rhythm are clinically attractive but require further investigation before their ...
openaire +3 more sources
Alcohol and Ventricular Arrhythmia
Annals of Internal Medicine, 1973Excerpt To the editor: The design of the study reported in "Ventricular Arrhythmias Associated with the Ingestion of Alcohol," by Singer and Lundberg (Ann Intern Med77:247-248, 1972), was such that...
H, Yazici, K, Singer, W V, Lundberg
openaire +3 more sources
Ventricular arrhythmias in the athlete
Current Opinion in Cardiology, 2001Life-threatening ventricular arrhythmias in the athlete nearly always occur in the presence of structural heart disease. In the last few years, 2 new causes of life-threatening arrhythmias have been described in patients with normal hearts-that of the Brugada syndrome and that of commotio cordis.
Paul J. Wang +2 more
openaire +3 more sources
Ventricular Arrhythmias And Diazepam
JAMA: The Journal of the American Medical Association, 1971To the Editor.— Barrett and Hey's description of ventricular arrhythmias associated with the intravenous use of diazepam ( 214 :1323, 1970) illustrates some of the difficulties in drawing conclusions from uncontrolled isolated case reports. Their first patient had a short burst of ventricular tachycardia after direct current shock, a not infrequent ...
openaire +3 more sources
Mexiletine for ventricular arrhythmias
The American Journal of Cardiology, 1981Abstract Mexiletine, a new antiarrhythmic agent derived from lidocaine and available in oral form, was utilized in 108 patients with chronic and symptomatic ventricular arrhythmia. Recurrent ventricular tachycardia was present in 83 patients and considered refractory to antiarrhythmic therapy in 72.
Philip J. Podrid, Bernard Lown
openaire +3 more sources
Sleep and ventricular arrhythmias
American Heart Journal, 1983Sleep is usually associated with a reduction in the frequency of ventricular arrhythmias. We analyzed 1260 24-hour Holter recordings exhibiting ventricular ectopy and identified 50 patients who had significant increases in sleep-related ectopy. This study group was compared to an age, sex, and 24-hour ventricular ectopic frequency matched control group.
Eugene Uretz +2 more
openaire +3 more sources
Treatment of ventricular arrhythmias
Current Problems in Cardiology, 1988Within the past 20 years, our knowledge concerning the epidemiology, natural history, and treatment of VT has expanded greatly. A variety of effective pharmacologic, surgical and electrical therapies for VT are now available to the clinician. Patients who present with ventricular tachyarrhythmias should undergo a comprehensive medical evaluation ...
H Garan +2 more
openaire +3 more sources
Ablation of ventricular arrhythmias
Trends in Cardiovascular Medicine, 2014Ventricular arrhythmias (VAs) commonly occur in patients with structural heart disease and may present as ventricular premature depolarizations (VPDs), monomorphic ventricular tachycardia (VT), or polymorphic VT/ventricular fibrillation. Idiopathic VAs can also occur in patients with normal hearts.
Mouhannad M. Sadek +1 more
openaire +3 more sources
Pindolol for ventricular arrhythmia
American Heart Journal, 1982The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder. Of these patients, 23 had coronary heart disease, 5 had valvular disease, and 15 had no demonstrable heart disease. patients underwent acute drug testing with 20 mg pindolol (phase 1) followed by maintenance therapy (phase 2) for 3 days (20 to 80 mg ...
Bernard Lown +3 more
openaire +3 more sources